“IRBM is an important Italian biotech centre , which is giving a strategic contribution to the development of one of the vaccines against Covid-19 , a very important reality from the scientific point of view at international level.
From October 24-25, our Vice President of North American Business Development, Dan Conlon, is attending the Peptide Therapeutics Symposium at the Salk Institute in California.
Now in its 14th year, the event unites key opinion leaders and eminent researchers in peptide research and innovation to discuss technological advances relevant to this expanding field. If you are attending and want to learn how our passion for science drives our exceptional peptide discovery capabilities then contact Dan to arrange a meeting. https://www.irbm.com/contact-us/